7MM parkinson’s disease market to hit $7.9b by 2033

The number of diagnosed cases is expected to rise to 3.1 million.

The Parkinson’s disease (PD) market across the seven major markets (7MM) is projected to reach $7.9b in 2033 at a compound annual growth rate of 8.9%, according to GlobalData.

The sector’s expansion is attributed to the introduction of 10 pipeline drugs, wider adoption of novel levodopa delivery methods, and a rising number of PD cases driven by an ageing population.

The number of diagnosed PD cases in the 7MM is expected to rise to 3.1 million over the same period.

Meanwhile, treated cases are expected to increase to 2.3 million.

7MM = US, France, Germany, Italy, Spain, UK, and Japan.